AXIM Biotechnologies
AXIM Biotechnologies is a biotechnology-sector company identified by its name and domain aximbiotech.com; specific products, technology, customer segments, and operational status are not disclosed in the available source data.
- Company typePrivate
- Founded2010
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What AXIM Biotechnologies does
AXIM Biotechnologies is identified by its corporate name and the domain aximbiotech.com, which together indicate a positioning within the biotechnology sector. The company name itself signals a focus on biotechnological research, development, or commercialization, though no specific therapeutic area, modality, or product pipeline is described in the available source material. All other operational dimensions — products and services, proprietary technology, pricing model, go-to-market motion, customer segments, distribution channels, geographic footprint, partnerships, intellectual property, leadership, and operating status — are absent from the supplied data, and the company's own website was inaccessible due to a CAPTCHA/verification page, preventing any first-party validation.
No revenue figures, funding history, headcount, or financial disclosures are available in the source data. The provided metadata explicitly states that legal name, founding date, company type, operating status, revenue, and domicile could not be determined from available source data because the website was blocked. No management team, board, regulatory actions, mergers and acquisitions, restructuring events, or product launches are recorded in the supplied dataset. As a result, any further characterization of the company's business model, competitive positioning, or operational scale cannot be grounded in the input and is deliberately omitted from this description.
AXIM Biotechnologies firmographics
Firmographics- Name
- AXIM Biotechnologies
- Website
- https://aximbiotech.com
- Company type
- Private
- Founded year
- 2010
- Headcount range
- 11–50 employees
- Short description
- AXIM Biotechnologies is a biotechnology-sector company identified by its name and domain aximbiotech.com; specific products, technology, customer segments, and operational status are not disclosed in the available source data.
- Ownership category
- akta.pro rank
AXIM Biotechnologies industry classification
Industry- Product category
- Biotechnology
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI)
- akta.pro secondary industry
- Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)
Keywords
Where AXIM Biotechnologies is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
AXIM Biotechnologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
AXIM Biotechnologies product offering
Product offeringCore offering
The source data contains no information about what AXIM Biotechnologies fundamentally does or sells; the company's website was blocked by a CAPTCHA/verification page and no product or service descriptions were retrieved.
Differentiator
Problem solved
Functional benefit
AXIM Biotechnologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AXIM Biotechnologies competitors and assessment
Company assessmentDirect peers
- GW Pharmaceuticals: Developed cannabinoid-based prescription therapeutics (e.g., Sativex, Epidiolex) for neurological and rare disease indications. Historically the most direct comparator to AXIM's cannabinoid therapeutics platform.
- Zynerba Pharmaceuticals: Clinical-stage cannabinoid therapeutics company focused on transdermal cannabinoid formulations for neurological and inflammatory conditions, with overlapping therapeutic-area focus to AXIM's clinical programs.
- InMed Pharmaceuticals: Pharmaceutical company developing cannabinoid-based prescription therapeutics using both rare cannabinoid compounds and proprietary manufacturing approaches; comparable biotech/cannabinoid model.
- Tetra Bio-Pharma: Cannabinoid-derived prescription drug development company focused on oncology, ophthalmology, and pain — directly comparable therapeutic focus and small-cap biotech profile.
- Corbus Pharmaceuticals: Clinical-stage biopharmaceutical company that historically pursued cannabinoid receptor-targeting therapeutics for inflammatory and fibrotic diseases, providing a relevant peer comparable.
Market position
Weaknesses1 record
Competitive moat1 record
Key risks1 record
Customer concentration
AXIM Biotechnologies social profiles
Digital presenceAXIM Biotechnologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
AXIM Biotechnologies leadership team
Management profileNumber of profiles
AXIM Biotechnologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AXIM Biotechnologies M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AXIM Biotechnologies
What does AXIM Biotechnologies do?
The source data contains no information about what AXIM Biotechnologies fundamentally does or sells; the company's website was blocked by a CAPTCHA/verification page and no product or service descriptions were retrieved.
When was AXIM Biotechnologies founded?
AXIM Biotechnologies was founded in 2010. It employs 11 to 50 people.
Where is AXIM Biotechnologies based?
AXIM Biotechnologies is headquartered in New York, United States, in the North America region.
Who are AXIM Biotechnologies's main competitors?
Direct peers on record are GW Pharmaceuticals, Zynerba Pharmaceuticals, InMed Pharmaceuticals, Tetra Bio-Pharma and Corbus Pharmaceuticals.
Does AXIM Biotechnologies have an API?
No public API is recorded for AXIM Biotechnologies.
What industry is AXIM Biotechnologies in?
AXIM Biotechnologies's product category is Biotechnology. Its primary akta.pro industry code is HLAAAIAI, Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation), with a secondary code of HLAGAGAF, Analytical Development & QC Testing (Release/Stability/Potency). Its NAICS code is 541714 and its SIC code is 8731.